Goldberger On Education And Arms Control

Q: How healthy is U.S. science? GOLDBEGER: I think U.S. science is quite healthy in most of the forefront areas. In biology, it seems to be extremely strong. In condensed matter physics and related device physics, it’s very strong. In astronomy, astrophysics, there’s little question that the United States is the unchallenged world leader. In elementary particle physics and high energy physics, we have sort of a bifurcated situation. On the theoretical side, the United States is pro

Written byPeter Gwynne
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Q: How healthy is U.S. science?

GOLDBEGER: I think U.S. science is quite healthy in most of the forefront areas. In biology, it seems to be extremely strong. In condensed matter physics and related device physics, it’s very strong. In astronomy, astrophysics, there’s little question that the United States is the unchallenged world leader. In elementary particle physics and high energy physics, we have sort of a bifurcated situation. On the theoretical side, the United States is probably the world leader in elementary particle theory. On the experimental side, there’s little question that we’ve lost tremendous ground to the Europeans. The Soviet Union is not in the league, with the possible exception of their activities in theoretical physics. So, on the whole, American science is very strong.

But in a number of areas we’re clearly being challenged. In biology, to the extent that one regards sequencing the human genome as ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies